MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1682.15%
Quick Ratio
1682.15%
Cash Ratio
346.81%
Debt to Asset Ratio
9.44%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Right-of-use assets - operating ...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Treasury stock, at cost, 6,922,8...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
67,836
84,793
59,515
47,553
Marketable securities
256,004
29,940
84,726
114,313
Prepaid expenses and other current assets
5,188
3,771
5,498
8,254
Total current assets
329,028
118,504
149,739
170,120
Restricted cash and deposits
768
768
768
768
Right-of-use assets - operating lease
14,993
15,416
15,828
16,230
Other long-term assets
1,139
517
471
277
Property and equipment, gross
9,774
9,798
9,676
9,472
Lessaccumulated depreciation
7,573
7,326
7,052
6,843
Property and equipment, net
2,201
2,472
2,624
2,629
Total assets
348,129
137,677
169,430
190,024
Accounts payable
2,254
2,573
1,549
1,888
Short-term operating lease liability
3,292
3,267
3,243
3,220
Accrued expenses and other current liabilities
14,014
10,866
13,591
13,715
Total current liabilities
19,560
16,706
18,383
18,823
Long-term operating lease liability
13,302
13,724
14,134
14,534
Total liabilities
32,862
30,430
32,517
33,357
Common stock, 0.00001 par value, 150,000,000 authorized at june 30, 2026 and december 31, 2025, and 103,480,053 and 63,587,777 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
1
-
-
-
Additional paid-in capital
914,769
621,557
617,433
611,457
Treasury stock, at cost, 6,922,870 shares held at june 30, 2026 and no shares held at december 31, 2025
39,093
-
-
-
Accumulated deficit
-559,740
-514,103
-480,418
-454,859
Accumulated other comprehensive loss
-670
-207
-102
69
Total stockholders' equity
315,267
107,247
136,913
156,667
Total liabilities and stockholders' equity
348,129
137,677
169,430
190,024
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$256,004K (266.01%↑ Y/Y)Cash and cashequivalents$67,836K (-36.82%↓ Y/Y)Prepaid expenses andother current assets$5,188K (-21.95%↓ Y/Y)Property and equipment,gross$9,774K (3.68%↑ Y/Y)Total current assets$329,028K (78.86%↑ Y/Y)Right-of-use assets -operating lease$14,993K (-9.80%↓ Y/Y)Property and equipment,net$2,201K (-23.15%↓ Y/Y)Other long-termassets$1,139K (515.68%↑ Y/Y)Restricted cash anddeposits$768K (0.00%↑ Y/Y)Lessaccumulated depreciation$7,573K (15.39%↑ Y/Y)Total assets$348,129K (70.32%↑ Y/Y)Total liabilities andstockholders' equity$348,129K (70.32%↑ Y/Y)Total stockholders'equity$315,267K (80.54%↑ Y/Y)Total liabilities$32,862K (10.39%↑ Y/Y)Accumulated deficit-$559,740K (-30.56%↓ Y/Y)Treasury stock, at cost,6,922,870 shares held at...$39,093K Accumulated othercomprehensive loss-$670K (-2780.00%↓ Y/Y)Additional paid-in capital$914,769K (51.62%↑ Y/Y)Total currentliabilities$19,560K (31.70%↑ Y/Y)Long-term operating leaseliability$13,302K (-10.82%↓ Y/Y)Common stock, 0.00001par value,...$1K Accrued expenses andother current...$14,014K (35.14%↑ Y/Y)Short-term operating leaseliability$3,292K (203.00%↑ Y/Y)Accounts payable$2,254K (75.27%↑ Y/Y)

Aura Biosciences, Inc. (AURA)

Aura Biosciences, Inc. (AURA)